Proton Pump
Proton pump is a protein complex that transport the H+ ion across the membranes of lysosomes and vacuoles to generate an electrical and chemical gradient that provide energy for ATP synthesis from ADP.
Products Related to Proton Pump(58)
- GC32924Linaprazan (AZD0865)CAS: 248919-64-4Purity: >98.50%
Linaprazan (AZD0865) (AZD0865) inhibits gastric H+,K+-ATPase by K+-competitive binding.
- GC33575Esomeprazole potassium salt ((S)-Omeprazole potassium)CAS: 161796-84-5Purity: >98%
Esomeprazole potassium salt ((S)-Omeprazole potassium) ((S)-Omeprazole potassium salt) is a potent and orally active proton pump inhibitor and reduces acid secretion through inhibition of the H+, K+-ATPase in gastric parietal cells.
- GC36009Esomeprazole magnesium saltCAS: 1198768-91-0Purity: >98%
Esomeprazole magnesium salt ((S)-Omeprazole magnesium salt) is a potent and orally active proton pump inhibitor and reduces acid secretion through inhibition of the H+, K+-ATPase in gastric parietal cells.
- GC36806Omeprazole D3CAS: 922731-01-9Purity: >98.50%
Omeprazole D3 (H 16868-d3) is deuterium labeled Omeprazole.
- GC36847Pantoprazole sodiumCAS: 138786-67-1Purity: >99.50%
Pantoprazole sodium (BY10232 sodium) is an orally active and potent proton pump inhibitor (PPI).
- GC36848Pantoprazole sodium hydrateCAS: 164579-32-2Purity: >98.00%
Pantoprazole sodium hydrate (BY10232 sodium hydrate) is an orally active and potent proton pump inhibitor (PPI).
- GC37756Tenatoprazole sodiumCAS: 335299-59-7Purity: >98%
Tenatoprazole sodium (TU-199 sodium) is a proton pump inhibitor; inhibits hog gastric H+/K+-ATPase with an IC50 of 6.2 μM.
- GC37920VonoprazanCAS: 881681-00-1Purity: >99.50%
Vonoprazan (TAK-438 free base), a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity.
- GC39429Rabeprazole SulfideCAS: 117977-21-6Purity: >98.00%
Rabeprazole Sulfide is an active metabolite of Rabeprazole.
- GC47537Lansoprazole-d4CAS: 934294-22-1Purity: >99.00%
An internal standard for the quantification of lansoprazole
- GC605305-HydroxylansoprazoleCAS: 131926-98-2Purity: >99.50%
5-Hydroxylansoprazole (AG1908) is an active metabolite of Lansoprazole in plasma.
- GC60929Ilaprazole sodiumCAS: 172152-50-0Purity: >98.50%
Ilaprazole (IY-81149) sodium is an orally active proton pump inhibitor.
- GC60975Lansoprazole Sulfide D4CAS: 1216682-38-0Purity: >98%
Lansoprazole Sulfide D4 is a deuterium labeled Lansoprazole Sulfide.
- GC61155Omeprazole sodiumCAS: 95510-70-6Purity: >98.00%
Omeprazole sodium (H 16868 sodium), a proton pump inhibitor (PPI), is available for treatment of acid-related gastrointestinal disorders.
- GC61863VerucopeptinCAS: 138067-14-8Purity: >98.00%
Verucopeptin is a potent?HIF-1 (IC50=0.22 μM) inhibitor and decreases the expression of HIF-1 target genes and HIF-1α protein levels. Verucopeptin strongly inhibits v-ATPase activity?by directly targeting the v-ATPase ATP6V1G subunit but not ATP1V1B2 or ATP6V1D. Verucopeptin exhibits antitumor activity against multidrug resistance (MDR)?cancers and can be used for cancer research.
- GC62885Caloxin 2A1 TFAPurity: >99.50%
Caloxin 2A1 TFA is an extracellular plasma membrane Ca2+-ATPase (PMCA) peptide inhibitor.
- GC63472ZastaprazanCAS: 2133852-18-1Purity: >99.50%
Zastaprazan is a proton pump inhibitor (WO2018008929).
- GC63687Rabeprazole-d4CAS: 934295-48-4Purity: >98%
Rabeprazole D4 (LY307640 D4) is a deuterium labeled Rabeprazole.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC32924 | Linaprazan (AZD0865) | 248919-64-4 | >98.50% | |
Linaprazan (AZD0865) (AZD0865) inhibits gastric H+,K+-ATPase by K+-competitive binding. | ||||
| GC33575 | Esomeprazole potassium salt ((S)-Omeprazole potassium) | 161796-84-5 | >98% | |
Esomeprazole potassium salt ((S)-Omeprazole potassium) ((S)-Omeprazole potassium salt) is a potent and orally active proton pump inhibitor and reduces acid secretion through inhibition of the H+, K+-ATPase in gastric parietal cells. | ||||
| GC35982 | EN6 | 1808714-73-9 | >98.00% | |
An activator of autophagy | ||||
| GC36009 | Esomeprazole magnesium salt | 1198768-91-0 | >98% | |
Esomeprazole magnesium salt ((S)-Omeprazole magnesium salt) is a potent and orally active proton pump inhibitor and reduces acid secretion through inhibition of the H+, K+-ATPase in gastric parietal cells. | ||||
| GC36806 | Omeprazole D3 | 922731-01-9 | >98.50% | |
Omeprazole D3 (H 16868-d3) is deuterium labeled Omeprazole. | ||||
| GC36847 | Pantoprazole sodium | 138786-67-1 | >99.50% | |
Pantoprazole sodium (BY10232 sodium) is an orally active and potent proton pump inhibitor (PPI). | ||||
| GC36848 | Pantoprazole sodium hydrate | 164579-32-2 | >98.00% | |
Pantoprazole sodium hydrate (BY10232 sodium hydrate) is an orally active and potent proton pump inhibitor (PPI). | ||||
| GC37756 | Tenatoprazole sodium | 335299-59-7 | >98% | |
Tenatoprazole sodium (TU-199 sodium) is a proton pump inhibitor; inhibits hog gastric H+/K+-ATPase with an IC50 of 6.2 μM. | ||||
| GC37920 | Vonoprazan | 881681-00-1 | >99.50% | |
Vonoprazan (TAK-438 free base), a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity. | ||||
| GC39429 | Rabeprazole Sulfide | 117977-21-6 | >98.00% | |
Rabeprazole Sulfide is an active metabolite of Rabeprazole. | ||||
| GC39734 | Diphyllin | 22055-22-7 | >99.50% | |
Diphyllin is an arylnaphthalene lignan isolated from Justicia procumbens and is a potent HIV-1 inhibitor with an IC50 of 0.38 μM. | ||||
| GC47537 | Lansoprazole-d4 | 934294-22-1 | >99.00% | |
An internal standard for the quantification of lansoprazole | ||||
| GC60530 | 5-Hydroxylansoprazole | 131926-98-2 | >99.50% | |
5-Hydroxylansoprazole (AG1908) is an active metabolite of Lansoprazole in plasma. | ||||
| GC60929 | Ilaprazole sodium | 172152-50-0 | >98.50% | |
Ilaprazole (IY-81149) sodium is an orally active proton pump inhibitor. | ||||
| GC60975 | Lansoprazole Sulfide D4 | 1216682-38-0 | >98% | |
Lansoprazole Sulfide D4 is a deuterium labeled Lansoprazole Sulfide. | ||||
| GC61155 | Omeprazole sodium | 95510-70-6 | >98.00% | |
Omeprazole sodium (H 16868 sodium), a proton pump inhibitor (PPI), is available for treatment of acid-related gastrointestinal disorders. | ||||
| GC61863 | Verucopeptin | 138067-14-8 | >98.00% | |
Verucopeptin is a potent?HIF-1 (IC50=0.22 μM) inhibitor and decreases the expression of HIF-1 target genes and HIF-1α protein levels. Verucopeptin strongly inhibits v-ATPase activity?by directly targeting the v-ATPase ATP6V1G subunit but not ATP1V1B2 or ATP6V1D. Verucopeptin exhibits antitumor activity against multidrug resistance (MDR)?cancers and can be used for cancer research. | ||||
| GC62823 | Abeprazan | 1902954-60-2 | >99.50% | |
Abeprazan (DWP14012) is a potassium-competitive acid blocker. | ||||
| GC62885 | Caloxin 2A1 TFA | - | >99.50% | |
Caloxin 2A1 TFA is an extracellular plasma membrane Ca2+-ATPase (PMCA) peptide inhibitor. | ||||
| GC63335 | Omeprazole-13CD3 | 1261395-28-1 | >98% | |
| GC63472 | Zastaprazan | 2133852-18-1 | >99.50% | |
Zastaprazan is a proton pump inhibitor (WO2018008929). | ||||
| GC63687 | Rabeprazole-d4 | 934295-48-4 | >98% | |
Rabeprazole D4 (LY307640 D4) is a deuterium labeled Rabeprazole. | ||||
| GC63954 | KM91104 | 304481-60-5 | >99.00% | |
KM91104, a cell-permeable V-ATPase inhibitor, specifically targets the a3-b2 subunits of V-ATPase. | ||||
| GC64070 | Omeprazole-d3-1 | 934293-92-2 | >98% | |
